A Mechanistic Review on How Berberine Use Combats Diabetes and Related Complications: Molecular, Cellular, and Metabolic Effects.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing preclinical mechanisms and clinical studies without a systematic methodology.
PubMed 38275993 · doi:10.3390/ph17010007
What was done
This narrative mechanistic review synthesized literature from cellular, animal, and clinical studies examining the therapeutic effects and molecular pathways of berberine in type 2 diabetes and related complications.
What was found
The abstract reports no quantitative values or statistical metrics. It describes qualitative findings that berberine lowers fasting blood glucose, HbA1c, inflammatory cytokines, and oxidative stress markers, enhances insulin secretion, and up-regulates PPAR-γ, GLUT4, PI3K/AKT, and AMPK pathways while protecting against diabetic hepatic, cardiovascular, renal, and neural complications.
Why it matters
The review summarizes the broad molecular targets of berberine, highlighting its potential utility as an adjunctive multi-target agent for metabolic regulation.
Limits
The paper is a narrative review without a systematic search strategy, formal study quality assessment, or quantitative meta-analysis. The abstract provides no specific patient numbers, clinical dosing data, or safety profiles.
Cited by
- context Berberine is derived from tree bark and functions as a glucose scavenger.